Merck Serono News
Most Popular Merck Serono Story
Merck Serono, Theratechnologies ink $215M deal
Merck Serono has signed a deal to license the U.S. commercialization right to tesamorelin, a drug to treat excess abdominal fat in HIV patients with lipodystrophy. Theratechnologies retains rights to... Read more...
Latest Headlines
- October 29, 2008
- September 4, 2008
- June 18, 2008
- August 30, 2007
- August 29, 2007
- August 24, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
